Holen Sie sich die Stockscreener-App
4.18
0.00%
0.00
Handel nachbörslich:
4.18
Schlusskurs vom Vortag:
$4.18
Offen:
$4.16
24-Stunden-Volumen:
643.92K
Relative Volume:
0.58
Marktkapitalisierung:
$284.47M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.81M
KGV:
-2.2234
EPS:
-1.88
Netto-Cashflow:
$74.30M
1W Leistung:
-1.18%
1M Leistung:
+12.82%
6M Leistung:
-47.62%
1J Leistung:
+3.47%
1-Tages-Spanne:
$4.07
$4.245
1-Wochen-Bereich:
$4.07
$4.435
52-Wochen-Spanne:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Firmenname
Omeros Corporation
Sektor
Branche
Telefon
206-676-5000
Adresse
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Vergleichen Sie OMER mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
4.18 | 291.96M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-12-08 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2021-10-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2021-09-27 | Eingeleitet | JP Morgan | Neutral |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-08-21 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-14 | Bestätigt | Maxim Group | Buy |
| 2019-05-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-03-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-03-05 | Herabstufung | Needham | Buy → Hold |
| 2017-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Herabstufung | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Bestätigt | Maxim Group | Buy |
| 2017-03-17 | Bestätigt | Needham | Buy |
| 2016-11-16 | Bestätigt | Wedbush | Outperform |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-08-10 | Bestätigt | Maxim Group | Buy |
| 2016-06-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-02 | Bestätigt | Needham | Buy |
| 2016-02-29 | Bestätigt | Wedbush | Outperform |
| 2015-11-11 | Bestätigt | Needham | Buy |
| 2015-08-18 | Bestätigt | WBB Securities | Strong Buy |
| 2015-08-10 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Omeros Corporation Aktie (OMER) Neueste Nachrichten
What are Omeros Corporation’s recent SEC filings showingJuly 2025 Volume & Technical Pattern Based Signals - khodrobank.com
What’s next for Omeros Corporation stock priceMarket Trend Review & High Conviction Buy Zone Picks - Newser
Will Omeros Corporation rebound enough to break evenTrade Analysis Summary & Safe Swing Trade Setups - Newser
What momentum shifts mean for Omeros CorporationPortfolio Update Summary & Consistent Profit Trading Strategies - Newser
Advanced analytics toolkit walkthrough for Omeros Corporation2025 Market Outlook & Growth Focused Investment Plans - Newser
Omeros Corporation stock prediction for this week2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Sector ETF performance correlation with Omeros Corporation2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - Newser
Strategies to average down on Omeros CorporationMarket Activity Summary & Entry Point Strategy Guides - Newser
Custom watchlist performance reports with Omeros CorporationEarnings Risk Report & Precise Trade Entry Recommendations - Newser
Omeros Corporation’s volatility index tracking explainedJuly 2025 PostEarnings & Stepwise Entry and Exit Trade Signals - Newser
What is Omeros Corporation’s valuation compared to sector2025 Dividend Review & Daily Profit Maximizing Tips - khodrobank.com
Heatmap analysis for Omeros Corporation and competitorsTrend Reversal & Stepwise Trade Execution Plans - Newser
Is Omeros Corporation trending in predictive chart modelsPortfolio Performance Summary & Community Trade Idea Sharing - Newser
Predicting Omeros Corporation trend using moving averages2025 Earnings Impact & Accurate Intraday Trading Signals - Newser
Momentum divergence signals in Omeros Corporation chartJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - Newser
What Fibonacci levels say about Omeros Corporation reboundJuly 2025 Highlights & AI Forecast Swing Trade Picks - Newser
Is Omeros Corporation showing signs of accumulation2025 Earnings Impact & Weekly High Momentum Picks - Newser
Omeros Corporation stock retracement – recovery analysisJuly 2025 Final Week & Real-Time Volume Spike Alerts - Newser
What to do if you’re stuck in Omeros Corporation2025 Performance Recap & Community Trade Idea Sharing - Newser
What’s next for Omeros Corporation stockJuly 2025 Review & Technical Confirmation Trade Alerts - khodrobank.com
Should you wait for a breakout in Omeros CorporationWeekly Trend Recap & High Return Trade Opportunity Guides - Newser
Movement Recap: Can Omeros Corporation deliver alphaQuarterly Profit Review & Verified Short-Term Plans - khodrobank.com
Published on: 2025-09-02 14:26:02 - Newser
Order flow analysis tools used on Omeros CorporationGap Down & Daily Profit Maximizing Tips - Newser
Is Omeros Corporation stock ready for a breakoutWeekly Risk Summary & Weekly Market Pulse Alerts - Newser
Omeros announces publication of narsoplimab survival outcomes in TA-TMA - TipRanks
Omeros Announces Publication Highlighting Survival Outcomes in TA-TMA Patients Treated with Narsoplimab Under Its Global Expanded Access Program - Yahoo Finance
Is it time to cut losses on Omeros Corporation2025 Volume Leaders & Verified Momentum Stock Watchlist - Newser
Analyzing drawdowns of Omeros Corporation with statistical toolsBear Alert & Daily Price Action Insights - Newser
A | What’s next for Omeros Corporation stockTake Profit & High Conviction Buy Zone Picks - khodrobank.com
Will Omeros Corporation benefit from AI trendsJuly 2025 Levels & Daily Chart Pattern Signal Reports - khodrobank.com
Omeros Corporation Reports Positive Q2 Earnings with Reduced Net Loss, Extended Debt Maturity, and Progress in Narsoplimab Approval - AInvest
Is Omeros Corporation on track to beat earningsEarnings Growth Report & Daily Oversold Stock Bounce Ideas - khodrobank.com
Can Omeros Corporation navigate macro headwindsWeekly Risk Summary & High Yield Stock Recommendations - khodrobank.com
Omeros Corporation Forms Bullish Flag — Upside Ahead getLinesFromResByArray error: size == 0 - kangso.co.kr
Will Omeros Corporation benefit from rate cuts2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - khodrobank.com
Can Omeros Corporation outperform in the next rallyJuly 2025 WrapUp & Low Drawdown Trading Techniques - khodrobank.com
Is Omeros Corporation stock bottoming outJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - Newser
Is Omeros Corporation reversing from oversold territoryMarket Growth Review & AI Driven Price Forecasts - Newser
What to expect from Omeros Corporation in the next 30 daysWeekly Profit Recap & Real-Time Stock Price Movement Reports - Newser
Real time scanner hits for Omeros Corporation explainedTrend Reversal & AI Enhanced Execution Alerts - Newser
Omeros Corporation’s Positive Earnings Call Highlights Progress - TipRanks
Using AI based signals to follow Omeros CorporationJuly 2025 Technicals & Fast Moving Trade Plans - Newser
Omeros Corporation stock daily chart insightsMarket Volume Summary & Safe Swing Trade Setup Alerts - Newser
Signal strength of Omeros Corporation stock in tech scannersInflation Watch & Weekly Top Stock Performers List - Newser
Finanzdaten der Omeros Corporation-Aktie (OMER)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):